{"id":118,"date":"2020-04-28T09:35:47","date_gmt":"2020-04-28T09:35:47","guid":{"rendered":"https:\/\/nclinnovations.org\/covid19monitor\/?p=118"},"modified":"2020-05-12T05:15:59","modified_gmt":"2020-05-12T05:15:59","slug":"27-april-2020-update-on-clinical-studies-of-key-drug-molecules-for-covid-19","status":"publish","type":"post","link":"https:\/\/nclinnovations.org\/covid19monitor\/27-april-2020-update-on-clinical-studies-of-key-drug-molecules-for-covid-19\/","title":{"rendered":"(27 April 2020) Update on clinical studies of key drug molecules for COVID 19"},"content":{"rendered":"<div class=\"boldgrid-section\">\n<div class=\"container\">\n<div class=\"row\">\n<div class=\"col-md-12 col-xs-12 col-sm-12\">\n<p><strong>Update on treatment of COVID-19: ongoing studies between promising and disappointing results.<\/strong><\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32335561\">https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32335561<\/a><\/p>\n<p class=\"\">A compilation of results of trials going on (up to April 15, 2020)for key molecules used in treatment of COVID-19 is presented. Data for Chloroquine, hydroxychloroquine, remdesevir, favipiravir, lopinavir\/ritonavir, tocilizumab, convalescent plasma and immunoglobulins from preliminary studies seem to provide promising results for some of these drugs, some others are giving more disappointing information.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Update on treatment of COVID-19: ongoing studies between promising and disappointing results. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32335561 A compilation of results of trials going on (up to April 15, 2020)for key molecules used in treatment of COVID-19 is presented. Data for Chloroquine, hydroxychloroquine, remdesevir,&hellip; <span class=\"read-more-span\"><a href=\"https:\/\/nclinnovations.org\/covid19monitor\/27-april-2020-update-on-clinical-studies-of-key-drug-molecules-for-covid-19\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;(27 April 2020) Update on clinical studies of key drug molecules for COVID 19&#8221;<\/span> <span class=\"genericon genericon-next\"><\/span><\/a><\/span><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"bgseo_title":"","bgseo_description":"","bgseo_robots_index":"index","bgseo_robots_follow":"follow"},"categories":[6],"tags":[19,26,10,41,40,27],"_links":{"self":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/118"}],"collection":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/comments?post=118"}],"version-history":[{"count":1,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/118\/revisions"}],"predecessor-version":[{"id":119,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/118\/revisions\/119"}],"wp:attachment":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/media?parent=118"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/categories?post=118"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/tags?post=118"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}